Marcello Allegretti Selected Research

Interleukin-8A Receptors (Receptors, Interleukin 8A)

1/2022	The CXCR1/CXCR2 Inhibitor Reparixin Alters the Development of Myelofibrosis in the Gata1 low Mice.
5/2017	Multiple anti-tumor effects of Reparixin on thyroid cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marcello Allegretti Research Topics

Disease

10	Inflammation (Inflammations) 01/2022 - 03/2006
10	Neoplasms (Cancer) 01/2020 - 10/2006
6	COVID-19 08/2022 - 01/2021
6	Peripheral Nervous System Diseases (PNS Diseases) 05/2022 - 01/2017
6	Infections 05/2022 - 06/2008
6	Neuralgia (Stump Neuralgia) 04/2021 - 11/2014
5	Reperfusion Injury 08/2007 - 08/2004
4	Hyperalgesia 05/2022 - 11/2014
4	Pain (Aches) 04/2021 - 11/2014
3	Breast Neoplasms (Breast Cancer) 08/2022 - 12/2015
3	Pneumonia (Pneumonitis) 08/2022 - 01/2017
3	Keratitis 03/2022 - 01/2018
3	Neoplasm Metastasis (Metastasis) 01/2020 - 07/2012
2	Chronic Obstructive Pulmonary Disease (COPD) 06/2022 - 01/2020
2	Disease Progression 06/2022 - 01/2020
2	Virus Diseases (Viral Diseases) 05/2022 - 01/2017
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 04/2015
2	Parkinson Disease (Parkinson's Disease) 10/2021 - 09/2021
2	Mitochondrial Diseases (Mitochondrial Disease) 10/2021 - 09/2021
2	Blindness (Hysterical Blindness) 09/2021 - 01/2021
2	Retinal Diseases 09/2021 - 01/2021
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2021
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 07/2019
2	Neuroinflammatory Diseases 12/2020 - 07/2019
2	Human Influenza (Influenza) 01/2020 - 01/2017
2	Ovarian Neoplasms (Ovarian Cancer) 12/2011 - 04/2009
1	Bacterial Infections (Bacterial Infection) 06/2022
1	Severe Acute Respiratory Syndrome 06/2022
1	Hypersensitivity (Allergy) 05/2022
1	Anaphylaxis (Anaphylactic Shock) 05/2022
1	Hyperplasia 01/2022
1	Primary Myelofibrosis (Myelosclerosis) 01/2022
1	Myopia 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 01/2022
1	Hemorrhage 01/2022
1	Epilepsy (Aura) 10/2021
1	Seizures (Absence Seizure) 10/2021
1	Status Epilepticus (Complex Partial Status Epilepticus) 10/2021
1	Atrophy 01/2021

Drug/Important Bio-Agent (IBA)

11	reparixinIBA 08/2022 - 08/2004
10	Interleukin-8 (Interleukin 8)IBA 10/2021 - 03/2006
8	Chemokine ReceptorsIBA 01/2022 - 08/2004
7	Pharmaceutical PreparationsIBA 05/2022 - 06/2005
6	ChemokinesIBA 01/2022 - 06/2008
6	2'- ((4'- trifluoromethanesulfonyloxy)phenyl)- N- methanesulfonylpropionamideIBA 01/2022 - 03/2006
5	CytokinesIBA 06/2022 - 01/2017
4	Proteins (Proteins, Gene)FDA Link 05/2022 - 10/2009
4	Nerve Growth Factor (NGF)IBA 03/2022 - 01/2018
3	Raloxifene Hydrochloride (Evista)FDA Link 06/2022 - 01/2022
3	Paclitaxel (Taxol)FDA LinkGeneric 05/2022 - 12/2015
3	AntioxidantsIBA 10/2021 - 01/2021
3	CXC ChemokinesIBA 01/2017 - 03/2006
2	Carbocysteine (S-Carboxymethylcysteine)IBA 06/2022 - 10/2021
2	VaccinesIBA 05/2022 - 01/2022
2	Antiviral Agents (Antivirals)IBA 05/2022 - 01/2022
2	Selective Estrogen Receptor Modulators (SERM)IBA 05/2022 - 01/2022
2	Interleukin-8A Receptors (Receptors, Interleukin 8A)IBA 01/2022 - 05/2017
2	CollagenIBA 01/2022 - 01/2020
2	DF2755AIBA 01/2022 - 01/2016
2	Interleukin-8B ReceptorsIBA 10/2021 - 09/2004
2	Retinaldehyde (Retinal)IBA 09/2021 - 01/2021
2	Taurine FDA Link 09/2021 - 01/2021
2	Insulin (Novolin)FDA Link 01/2021 - 10/2009
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 07/2019
2	LigandsIBA 02/2017 - 03/2006
2	Peroxidase (Myeloperoxidase)IBA 01/2017 - 01/2016
2	Folic Acid (Vitamin M)FDA LinkGeneric 12/2011 - 04/2009
1	Expectorants (Mucolytics)IBA 06/2022
1	MucinsIBA 06/2022
1	Immunologic Factors (Immunomodulators)IBA 06/2022
1	Antineoplastic Agents (Antineoplastics)IBA 05/2022
1	Viral ProteinsIBA 05/2022
1	Complement C5a (Complement 5a)IBA 05/2022
1	Estrogen ReceptorsIBA 05/2022
1	Angiotensin-Converting Enzyme 2IBA 05/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	Tamoxifen FDA LinkGeneric 01/2022
1	Interleukin-8 ReceptorsIBA 01/2022
1	Estrogen Receptor AntagonistsIBA 01/2022
1	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	Reticulin (Reticular Fiber)IBA 01/2022
1	C-PeptideIBA 01/2022
1	Sulfides (Thioethers)IBA 10/2021
1	Cysteine (L-Cysteine)FDA Link 10/2021
1	sulfoxideIBA 10/2021
1	Kainic Acid (Kainate)IBA 10/2021
1	Amino Acids FDA Link 09/2021
1	Methionine (L-Methionine)FDA Link 09/2021
1	Complement C5 (Complement 5)IBA 04/2021
1	Complement System Proteins (Complement)IBA 04/2021
1	Valine (L-Valine)FDA Link 01/2021
1	Alanine (L-Alanine)FDA Link 01/2021
1	AlbuminsIBA 01/2021
1	Branched-Chain Amino AcidsIBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 01/2021

Therapy/Procedure

8	Therapeutics 03/2022 - 04/2009
5	Drug Therapy (Chemotherapy) 05/2022 - 01/2017
1	Operative Surgical Procedures 01/2022